Product Development Advisory Committee

The Advisory Committee on Product Development provides targeted advice to the Oversight Committee concerning the agency’s product development program. Examples of issues include:

  1. General contractual revenue sharing provisions that provide a fair return for the State of Texas while not discouraging follow-on funding from other sources;
  2. Appropriate portfolio mix of product development awards by stage of company and size of award; and
  3. Strategies to expand and encourage relocation of high quality companies to Texas.

Members:

Bruce Butler, Ph.D. 
Vice President, Research & Technology; Director, Office of Technology Management
The University of Texas Health Science Center at Houston

Kevin M. Lalande, M.B.A.
Managing Director
Santé Ventures

Martin Lindenberg, M.D.
Partner
Newport Board Group

Bruce Mackler, Ph.D.
Board Member, Prairie Plan Systems, Inc.
Board Member, OncoFluor, Inc.,
Board Member, Immunomic Therapeutics, Inc.
Venture Partner, TVM-Capital
FDA Advisor

Jonathan MacQuitty, Ph.D.
Partner
Abingworth

George McLendon, Ph.D.
Provost, Rice University
Co-Director, Texas Medical Center Accelerator (TMCx)

Debra Peattie, Ph.D.
Entrepreneur in Residence
GlaxoSmithKline

Emma Schwartz, M.P.H
President
Medical Center of the Americas Foundation

James (Jamie) Topper, M.D., Ph.D.
General Partner
Frazier Healthcare